Recombinant Human PAR4 Protein，His & GST

PAR4 (prostate apoptosis response-4) is a tumor suppressor protein that plays a crucial role in regulating apoptosis and cell survival, thus being of significant interest in cancer research. Initially identified for its expression in prostate tissues, PAR4 has been found to be involved in various cellular processes, including cell cycle regulation and response to stress. Its unique feature is the ability to induce tumor cell death through a selective apoptosis pathway, making it a potential target for therapeutic interventions in cancer treatment, particularly in prostate cancer. Recent studies have highlighted the importance of PAR4 in enhancing the sensitivity of cancer cells to chemotherapy and radiation, suggesting that modulating its activity could improve treatment outcomes. Furthermore, research has explored the mechanisms by which PAR4 functions, including its interactions with other cellular proteins and its role in various signaling pathways. Given the rising incidence of prostate and other cancers, understanding the function and mechanisms of PAR4 reconstituted proteins could offer new insights into cancer biology and lead to the development of novel therapeutic strategies. The investigation of PAR4 may not only shed light on potential cancer treatments but also enhance the understanding of apoptosis and the complexities of tumor biology, thereby contributing significantly to the field of oncology.